TSMC Adopts Synopsys Galaxy Custom Designer as iPDK Development and Validation Platform

Synopsys, Inc. (NASDAQ:SNPS) , a world leader in software and IP for semiconductor design, verification and manufacturing, today announced that Synopsys and TSMC have entered into a comprehensive multi-year agreement to jointly develop, validate, support and distribute interoperable process design kits (iPDKs) that are optimized for TSMC advanced semiconductor processes including the 65-nanometer (nm), 40-nm and 28-nm nodes. The agreement is the culmination of a two-year collaboration to establish an interoperable PDK ecosystem that can accelerate and broaden designer access to new process nodes, promote design reuse and enable greater analog, mixed-signal and RF design innovation. Additionally, TSMC has adopted Synopsys' Galaxy Custom Designer(TM) implementation solution as its iPDK development and validation platform.

"We are creating new business models and innovations such as iPDK under TSMC's Open Innovation Platform(TM)," said ST Juang, senior director of Design Infrastructure Marketing at TSMC. "Synopsys has a highly skilled and dedicated team with expertise in developing advanced, high-quality interoperable PDKs, and offers the industry's most open custom design platform that supports iPDKs. This collaborative approach will help to more quickly deliver iPDKs to our mutual customers so that they can begin capitalizing on the benefits of an interoperable ecosystem."

Synopsys was lead developer in the collaborative effort to develop and validate a complete TSMC 65-nm iPDK. Working directly with the TSMC PDK development team and other EDA vendors, Synopsys developed an iPDK that supports the analog, mixed-signal and RF flow on multiple EDA vendor tools. Synopsys and TSMC also collaborated on implementing a comprehensive iPDK development and validation solution based on Custom Designer. TSMC validated its recently-announced 65-nm iPDK to work with Synopsys' custom design solution, including Custom Designer, HSPICE circuit simulation, CustomSim(TM) circuit simulation, IC Validator/Hercules(TM) LVS/DRC and Star-RCXT(TM) extraction.

"Open standards are the catalyst for accelerating innovation, increasing competition and fostering growth in the electronics industry," said Paul Lo, senior vice president and general manager of the Analog/Mixed-Signal Group at Synopsys. "Synopsys' open-environment custom design platform and interoperable PDK expertise, coupled with TSMC's comprehensive PDK production capability, has enabled us to move the industry forward to realize the benefits of an interoperable custom design ecosystem. This is a major step for the entire semiconductor industry."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TSMC Taiwan Semiconductor Manufacturing Company. (2019, March 19). TSMC Adopts Synopsys Galaxy Custom Designer as iPDK Development and Validation Platform. AZoNano. Retrieved on April 14, 2024 from https://www.azonano.com/news.aspx?newsID=12696.

  • MLA

    TSMC Taiwan Semiconductor Manufacturing Company. "TSMC Adopts Synopsys Galaxy Custom Designer as iPDK Development and Validation Platform". AZoNano. 14 April 2024. <https://www.azonano.com/news.aspx?newsID=12696>.

  • Chicago

    TSMC Taiwan Semiconductor Manufacturing Company. "TSMC Adopts Synopsys Galaxy Custom Designer as iPDK Development and Validation Platform". AZoNano. https://www.azonano.com/news.aspx?newsID=12696. (accessed April 14, 2024).

  • Harvard

    TSMC Taiwan Semiconductor Manufacturing Company. 2019. TSMC Adopts Synopsys Galaxy Custom Designer as iPDK Development and Validation Platform. AZoNano, viewed 14 April 2024, https://www.azonano.com/news.aspx?newsID=12696.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.